JavaScript is disabled for your browser. Some features of this site may not work without it.
    • العربية
    • 中文
    • English
    • français
    • русский
    • español
    • Deutsch
    • português
français
  • العربية
  • 中文
  • English
  • français
  • русский
  • español
  • Deutsch
  • português
  • Accueil
  • Contact
  • Aide

Parcourir

Tout IRISCommunautés & CollectionsPar date de publicationAuteursTitresSujetsCette collectionPar date de publicationAuteursTitresSujets

Statistiques

Publications les plus consultéesGéolocalisation

Liens connexes

WPRO IRISPAHO IRIS

Evaluation of purified monoclonal antibodies to Bordetella pertussis fimbriae type 2 and 3 : study report and proposal to establish WHO reference reagents / D. Xing ... [‎et al]‎

Thumbnail
Voir/Ouvrir
WHO_BS_04.1998_eng.pdf (‎2.081Mo)‎
Statistiques
Consulter les statistiques
Altmetrics
Partager
Citation
Xing, D, Corbel, M. J, Newland, P, World Health Organization. Biologicals Unit & WHO Expert Committee on Biological Standardization (‎2004 : Geneva, Switzerland)‎. (‎2004)‎. Evaluation of purified monoclonal antibodies to Bordetella pertussis fimbriae type 2 and 3 : study report and proposal to establish WHO reference reagents / D. Xing ... [‎et al]‎. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/69928
Description
Presented at the meeting of the Expert Committee on Biological Standardization, Geneva, 15 to 19 November 2004
WHO/BS/04.1998
38 p.
Gov't Doc #
WHO/BS/04.1998
Collections
  • Documents Techniques
Langue
English
Métadonnées
Afficher la fiche complète

Documents associés

Affichage des documents associés par titre, auteur, créateur et sujet.

  • Vignette

    International collaborative study : evaluation of proposed international standard monoclonal antibodies for serotyping bordetella pertussis fimbrial antigen 2 and fimbrial antigen 3 / by D. Xing, P. Newland and M. Corbel 

    Xing, D; World Health Organization. Biologicals Unit; Newland, P; Corbel, M; WHO Expert Committee on Biological Standardization (‎2009 : Geneva, Switzerland)‎ (‎WHO/BS/09.2120, 2009)‎
  • Aucune version éléctronique

    Hybridoma technology with special reference to parasitic diseases : a notebook of papers and techniques presented at two courses: The Use of Monoclonal Antibodies in the Study of Parasitic Diseases, held in Epalinges-sur-Lausanne, Switzerland, 1-5 October l979 and Hybridoma Technology with Special Reference to Parasitic Diseases, held in Belo Horizonte, Brazil, 19-23 November 1979 

    UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (‎1980)‎
  • Vignette

    Report of a collaborative study to assess the suitability of candidate reference material to serve as the first WHO reference reagent dengue virus antibody and to standardize the neutralization test for dengue viruses / Morag Ferguson ... [‎et al]‎ 

    Ferguson, Morag; Johnes, S; Heath, Alan; World Health Organization. Biologicals Unit; WHO Expert Committee on Biological Standardization (‎2005 : Geneva, Switzerland)‎ (‎WHO/BS/05.2009, 2005)‎

Consulter les statistiques

Voir le document 
  • Accueil de IRIS
  • 1. Siège
  • Documents Techniques
  • Voir le document
  • Accueil de IRIS
  • 1. Siège
  • Documents Techniques
  • Voir le document

© OMS 2017